Your browser doesn't support javascript.
loading
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients.
Konicki, Robyn; Weiner, Daniel; Herbert Patterson, J; Gonzalez, Daniel; Kashuba, Angela; Cao, Yanguang Carter; Gehi, Anil K; Watkins, Paul; Powell, J Robert.
Afiliação
  • Konicki R; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Weiner D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Herbert Patterson J; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Kashuba A; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Cao YC; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Gehi AK; Division of Cardiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Watkins P; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Powell JR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Clin Transl Sci ; 13(4): 777-784, 2020 07.
Article em En | MEDLINE | ID: mdl-32267996

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article